Description
Bracanat™ is a quality assured generic of Lynparza® used to treat advanced ovarian cancer, fallopian tube cancer, and primary peritoneal cancer in women with an abnormal BRCA gene. It’s also used to treat metastatic HER2-negative breast cancer before or after chemotherapy or hormonal treatment. Additionally, it’s used to treat prostate cancer with specific abnormal genes. Moreover, it’s used to treat pancreatic cancer in patients with a specific abnormal inherited gene. It’s produced in a US FDA approved factory in India.
Bottle Size : 30 Tablets
Active Ingredient : Olaparib
Produced by Natco Pharma Ltd®